CoChat

Gestational Diabetes Identifies Women at Risk for Permanent Type 1 and Type 2 Diabetes in Fertile Age

Järvelä, Ilkka Y., Juutinen, Jaana, Koskela, Pentti, Hartikainen, Anna-Liisa, Kulmala, Petri, Knip, Mikael, Tapanainen, Juha S. · 2006 · Diabetes Care
Cited by 145

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

OBJECTIVE—Our aim was to evaluate the predictive value of gestational diabetes mellitus (GDM), diabetes-associated autoantibodies, and other factors for development of clinical diabetes later in life. RESEARCH DESIGN AND METHODS—In this case-control study the presence of autoantibodies was studied in 435 women with GDM and in healthy matched control subjects. The need for exogenous insulin during GDM was recorded. In the GDM group, the mean follow-up period was 5.7 years and in the control group 6.1 years. RESULTS—Among the subjects with GDM, 20 (4.6%) developed type 1 diabetes and 23 (5.3%) developed type 2 diabetes, whereas none of the control subjects became diabetic. Two-thirds of those who developed type 1 diabetes tested positive initially for islet cell antibodies (ICAs), whereas 56% of them had autoantibodies to GAD (GADAs) and 38% to the protein tyrosine phosphatase–related IA-2 molecule. Only 2 of the 23 women who presented later with type 2 diabetes tested positive for autoantibodies. According to multivariate analysis, initial age ≤30 years, the need for insulin treatment for GDM, and antibody positivity for ICAs and GADAs were associated with increased risk for clinical type 1 diabetes. CONCLUSIONS—Pregnancy seems to identify women who are at risk of developing diabetes later in life. About 10% of Finnish women with GDM will develop diabetes over the next 6 years; nearly half of them develop type 1 diabetes and the other half type 2 diabetes. Age ≤30 years, the need for insulin treatment during pregnancy, and positivity for ICAs and GADAs confer a high risk of subsequent progression to type 1 diabetes in women affected by GDM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diacare.29.03.06.dc05-1118

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 20

  1. Buchanan TA, Kjos SL: Gestational diabetes: risk or myth? J Clin Endocrinol Metab 84: 1854–1857, 1999 · DOI · Paper page
  2. Catalano PM, Tyzbir ED, Sims EA: Incidence and significance of islet cell antibodies in women with previous gestational diabetes. Diabetes Care 13: 478–482, 1990 · DOI · Paper page
  3. Ziegler AG, Hillebrand B, Rabl W, Mayrhofer M, Hummel M, Mollenhauer U, Vordemann J, Lenz A, Standl E: On the appearance of islet associated autoimmunity in offspring of diabetic mothers: a prospective study from birth. Diabetologia 36: 402–408, 1993 · DOI
  4. Palmer JP: What is the best way to predict IDDM? Lancet 343: 1377–1378, 1994 · DOI
  5. Fuchtenbusch M, Ferber K, Standl E, Ziegler AG: Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter study. Diabetes 46: 1459–1467, 1997 · DOI
  6. Tuomilehto J, Zimmet P, Mackay IR, Koskela P, Vidgren G, Toivanen L, Tuomilehto-Wolf E, Kohtamaki K, Stengard J, Rowley MJ: Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet 343: 1383–1385, 1994 · DOI · Paper page
  7. Dozio N, Beretta A, Belloni C, Castiglioni M, Rosa S, Bosi E, Bonifacio E: Low prevalence of islet autoantibodies in patients with gestational diabetes mellitus. Diabetes Care 20: 81–83, 1997 · DOI
  8. Mauricio D, Corcoy R, Codina M, Morales J, Balsells M, de Leiva A: Islet cell antibodies and beta-cell function in gestational diabetic women: comparison to first-degree relatives of type 1 (insulin-dependent) diabetic subjects. Diabet Med 12:1009–1014, 1995 · DOI
  9. McEvoy RC, Franklin B, Ginsberg-Fellner F: Gestational diabetes mellitus: evidence for autoimmunity against the pancreatic beta cells. Diabetologia 34: 507–510, 1991 · DOI
  10. Balsells M, Corcoy R, Mauricio D, Morales J, Garcia-Patterson A, Carreras G, Puig-Domingo M, de Leiva A: Insulin antibody response to a short course of human insulin therapy in women with gestational diabetes. Diabetes Care 20: 1172–1175, 1997 · DOI
  11. Reunanen A, Kangas T, Martikainen J, Klaukka T: Nationwide survey of comorbidity, use, and costs of all medications in Finnish diabetic individuals. Diabetes Care 23: 1265–1271, 2000 · DOI
  12. Kulmala P, Savola K, Petersen JS, Vahasalo P, Karjalainen J, Lopponen T, Dyrberg T, Akerblom HK, Knip M: Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes: a population-based study: the Childhood Diabetes in Finland Study Group. J Clin Invest 101: 327–336, 1998 · DOI · Paper page
  13. Hosmer D, Lemeshow S: Applied Logistic Regression. New York, John Wiley, 1989, p. 140–145 · DOI · Paper page
  14. Damm P, Kuhl C, Bertelsen A, Molsted-Pedersen L: Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus. Am J Obstet Gynecol 167: 607–616, 1992 · DOI · Paper page
  15. Linne Y, Barkeling B, Rossner S: Natural course of gestational diabetes mellitus: long term follow up of women in the SPAWN study. BJOG 109: 1227–1231, 2002 · DOI
  16. Beischer NA, Wein P, Sheedy MT, Mackay IR, Rowley MJ, Zimmet P: Prevalence of antibodies to glutamic acid decarboxylase in women who have had gestational diabetes. Am J Obstet Gynecol 173: 1563–1569, 1995 · DOI
  17. Steinhart JR, Sugarman JR, Connell FA: Gestational diabetes is a herald of NIDDM in Navajo women: high rate of abnormal glucose tolerance after GDM. Diabetes Care 20: 943–947, 1997 · DOI · Paper page
  18. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539–553, 1998 · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
  19. Pozzilli P, Di Mario U: Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention. Diabetes Care 24: 1460–1467, 2001 · DOI · Paper page
  20. Christie MR, Roll U, Payton MA, Hatfield EC, Ziegler AG: Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins. Diabetes Care 20: 965–970, 1997 · DOI

Cited by

See all 145

Metadata

Authors
Järvelä, I. Y., Juutinen, J., Koskela, P., Hartikainen, A.-L., Kulmala, P., Knip, M., & Tapanainen, J. S.
Venue
Diabetes Care
Published
2006-03-01
Volume
29
Issue
3
Pages
607-612
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W1995141200
Cited by
145
References
3
FWCI
11.93
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gestational Diabetes Identifies Women at Risk for Permanent Type 1 and Type 2 Diabetes in Fertile Age. https://app.cochat.ai/papers/10.2337/diacare.29.03.06.dc05-1118
The paper
Järvelä, I. Y., Juutinen, J., Koskela, P., Hartikainen, A.-L., Kulmala, P., Knip, M., & Tapanainen, J. S. (2006). Gestational Diabetes Identifies Women at Risk for Permanent Type 1 and Type 2 Diabetes in Fertile Age. Diabetes Care. https://doi.org/10.2337/diacare.29.03.06.dc05-1118

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.